Novo Nordisk and Nvidia announced a groundbreaking partnership aimed at developing supercomputers focused on pharmaceutical and other healthcare applications.
The project entails constructing a supercomputer in Denmark utilizing Nvidia's DGX SuperPOD and other AI-focused equipment from Nvidia.
Eli Lilly, Novo Nordisk's rival in the weight-loss category, is working with China-based XtalPi to accelerate drug discovery and development using AI.
